BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2021
View Archived Issues
Debiopharm identifies new enoyl-(acyl-carrier protein) reductase FabI inhibitors
Read More
Beijing Tide Pharmaceutical patents PROTACs targeting mutant EGFR
Read More
New furaneol glycoside compounds divulged by Fudan University
Read More
Janssen Pharmaceutical discovers compounds for hepatitis B
Read More
Condensate drugs block RSV replication in vivo
Read More
ALG2-CDG model in zebrafish displays human phenotypes and hypo-N-glycosylation
Read More
EscharEx debridement agent demonstrates efficiency, safety in chronic wound study
Read More
Hummingbird and MD Anderson collaborate to advance VISTA antagonist antibody, HMBD-002
Read More
First patient treated in phase I study of INKmune in high-risk MDS
Read More
Dosing begins in phase I study of CB-010 in B-cell NHL
Read More
Identification of antivirulence compound ANT-3273 for P. aeruginosa infection
Read More
Aptorum reports further interim phase I data on ALS-4
Read More
Prokineticin-2 as therapeutic target for prevention of neuronal death
Read More
Qixleef phase II protocol modifications approved
Read More
Immunic presents new preclinical and clinical data for IMU-935
Read More
Patients dosed in phase I/II trial of topical RECCE-327 for infected burn wounds
Read More
Vaccibody and Adaptive Biotechnologies sign license agreement on SARS-CoV-2 T-cell epitopes
Read More
Uproleselan studied with venetoclax and azacitidine for older or unfit patients with AML
Read More
Safety and immunogenicity of BNT-162b1 confirmed in phase I study in Chinese adults
Read More
FDA clears Tevogen Bio's IND application for TVGN-489 for COVID-19
Read More
Cellectar collaborates with LegoChemBio on first-in-class phospholipid drug conjugates
Read More
High annexin-2 levels worsen lung injury in patients with COVID-19
Read More
Akeso completes phase I trial of AK-117 and gains clearance for phase Ib/II trial in AML
Read More
Carna reports phase I SAD data on BTK inhibitor AS-0871
Read More